✦ LIBER ✦

Cardiac safety of formoterol 12 μg twice daily in patients with chronic obstructive pulmonary disease

✍ Scribed by Sammy C. Campbell; Gerard J. Criner; Bernard E. Levine; Stuart J. Simon; Jonathan S. Smith; Chadwick J. Orevillo; Barbara A. Ziehmer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Salmeterol and Formoterol in P

✍ M. Cazzola; G. Santangelo; A. Piccolor; A. Salzillo; M.G. Matera; G. D'Amato; F. 📂 Article 📅 1994 🏛 Elsevier 🌐 English ⚖ 233 KB

The Safety of ECT in Patients With Chron

✍ Kathryn M. Schak; Paul S. Mueller; Roxann D. Barnes; Keith G. Rasmussen 📂 Article 📅 2008 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 65 KB

Safety and tolerability of high-dose for

✍ Bernd Rosenkranz; Regine Rouzier; Matthias Kruse; Clair Dobson; Gareth Ayre; Ann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Practicability and safety of dipyridamol

✍ Robert Thurnheer; Irène Laube; Philipp A. Kaufmann; Kathrin D. M. Stumpe; Uz Sta 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 51 KB

A10/291 – Efficacy and safety of cicleso

✍ J.H. Vermeulen; T. Latos; U. Freudensprung; C. Stader; H. Rauer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety of budesonide/formot

✍ Zhong, Nanshan; Zheng, Jinping; Wen, Fuqiang; Yang, Lan; Chen, Ping; Xiu, Qingyu 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 313 KB

Cardiac safety of formoterol 12&#xa0;μg twice daily in patients with chronic obstructive pulmonary disease